{"title":"血浆血清素作为儿童和超重/肥胖中注意缺陷多动障碍严重程度的生物标志物","authors":"Gabriel Manjarrez-Gutiérrez , Martha Cristina Fernández-Cruz , Chiharu Murata , Teresa Neri-Gómez","doi":"10.1016/j.arcmed.2025.103259","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>Recently, the potential use of plasma serotonin concentration as a biomarker for various diseases has been reported. However, whether plasma serotonin levels are useful for diagnosing attention deficit hyperactivity disorder (ADHD) remains controversial. To evaluate 5-hydroxytryptamine (5-HT, serotonin) as a biomarker for ADHD diagnosis, its severity, and overweight/obesity in school-aged children.</div></div><div><h3>Methods</h3><div>Eighty-nine school-aged children (20 controls and 69 with ADHD: 17 hyperactive, 26 inattentive, and 26 mixed) were analyzed. Free 5-HT (5-HT<sub>F</sub>) and platelet 5-HT (5-HT<sub>P</sub>) levels were compared for ADHD presence, severity, and obesity, respectively, using the Kruskal-Wallis test. Multiple regression models assessed the predictive value of 5-HT<sub>F</sub> and 5-HT<sub>P</sub> for the presence and severity of ADHD, adjusting for age and obesity. The diagnostic utility of 5-HT<sub>F</sub> was evaluated using odds ratios (OR) and area under the curve (AUC) from logistic regression.</div></div><div><h3>Results</h3><div>Patients with ADHD exhibited significantly elevated 5-HT<sub>F</sub> levels. No significant subgroup differences were found, but 5-HT<sub>F</sub> levels increased with ADHD severity. Higher 5-HT<sub>F</sub> levels were also observed in patients with overweight/obesity. Inverse trends were noted for 5-HT<sub>P</sub>, though less pronounced. Logistic regression showed a 71 % increase in ADHD odds for each 0.1 µmol/L rise in 5-HT<sub>F</sub>. ORs for ADHD severity were 8.77 (severe), 2.31 (moderate), and 0.45 (mild). The AUC for 5-HT<sub>F</sub> was 0.76 for ADHD diagnosis and 0.93 for moderate/severe ADHD.</div></div><div><h3>Conclusions</h3><div>Plasma 5-HT<sub>F</sub> concentration can be a useful biomarker for the ADHD diagnosis, its severity, and comorbidity with overweight/obesity in these patients.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103259"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Plasma Serotonin as a Biomarker of the Severity of Attention Deficit Hyperactivity Disorder, in Children and Overweight/Obesity\",\"authors\":\"Gabriel Manjarrez-Gutiérrez , Martha Cristina Fernández-Cruz , Chiharu Murata , Teresa Neri-Gómez\",\"doi\":\"10.1016/j.arcmed.2025.103259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and Aims</h3><div>Recently, the potential use of plasma serotonin concentration as a biomarker for various diseases has been reported. However, whether plasma serotonin levels are useful for diagnosing attention deficit hyperactivity disorder (ADHD) remains controversial. To evaluate 5-hydroxytryptamine (5-HT, serotonin) as a biomarker for ADHD diagnosis, its severity, and overweight/obesity in school-aged children.</div></div><div><h3>Methods</h3><div>Eighty-nine school-aged children (20 controls and 69 with ADHD: 17 hyperactive, 26 inattentive, and 26 mixed) were analyzed. Free 5-HT (5-HT<sub>F</sub>) and platelet 5-HT (5-HT<sub>P</sub>) levels were compared for ADHD presence, severity, and obesity, respectively, using the Kruskal-Wallis test. Multiple regression models assessed the predictive value of 5-HT<sub>F</sub> and 5-HT<sub>P</sub> for the presence and severity of ADHD, adjusting for age and obesity. The diagnostic utility of 5-HT<sub>F</sub> was evaluated using odds ratios (OR) and area under the curve (AUC) from logistic regression.</div></div><div><h3>Results</h3><div>Patients with ADHD exhibited significantly elevated 5-HT<sub>F</sub> levels. No significant subgroup differences were found, but 5-HT<sub>F</sub> levels increased with ADHD severity. Higher 5-HT<sub>F</sub> levels were also observed in patients with overweight/obesity. Inverse trends were noted for 5-HT<sub>P</sub>, though less pronounced. Logistic regression showed a 71 % increase in ADHD odds for each 0.1 µmol/L rise in 5-HT<sub>F</sub>. ORs for ADHD severity were 8.77 (severe), 2.31 (moderate), and 0.45 (mild). The AUC for 5-HT<sub>F</sub> was 0.76 for ADHD diagnosis and 0.93 for moderate/severe ADHD.</div></div><div><h3>Conclusions</h3><div>Plasma 5-HT<sub>F</sub> concentration can be a useful biomarker for the ADHD diagnosis, its severity, and comorbidity with overweight/obesity in these patients.</div></div>\",\"PeriodicalId\":8318,\"journal\":{\"name\":\"Archives of Medical Research\",\"volume\":\"57 1\",\"pages\":\"Article 103259\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Medical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0188440925000797\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0188440925000797","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Plasma Serotonin as a Biomarker of the Severity of Attention Deficit Hyperactivity Disorder, in Children and Overweight/Obesity
Background and Aims
Recently, the potential use of plasma serotonin concentration as a biomarker for various diseases has been reported. However, whether plasma serotonin levels are useful for diagnosing attention deficit hyperactivity disorder (ADHD) remains controversial. To evaluate 5-hydroxytryptamine (5-HT, serotonin) as a biomarker for ADHD diagnosis, its severity, and overweight/obesity in school-aged children.
Methods
Eighty-nine school-aged children (20 controls and 69 with ADHD: 17 hyperactive, 26 inattentive, and 26 mixed) were analyzed. Free 5-HT (5-HTF) and platelet 5-HT (5-HTP) levels were compared for ADHD presence, severity, and obesity, respectively, using the Kruskal-Wallis test. Multiple regression models assessed the predictive value of 5-HTF and 5-HTP for the presence and severity of ADHD, adjusting for age and obesity. The diagnostic utility of 5-HTF was evaluated using odds ratios (OR) and area under the curve (AUC) from logistic regression.
Results
Patients with ADHD exhibited significantly elevated 5-HTF levels. No significant subgroup differences were found, but 5-HTF levels increased with ADHD severity. Higher 5-HTF levels were also observed in patients with overweight/obesity. Inverse trends were noted for 5-HTP, though less pronounced. Logistic regression showed a 71 % increase in ADHD odds for each 0.1 µmol/L rise in 5-HTF. ORs for ADHD severity were 8.77 (severe), 2.31 (moderate), and 0.45 (mild). The AUC for 5-HTF was 0.76 for ADHD diagnosis and 0.93 for moderate/severe ADHD.
Conclusions
Plasma 5-HTF concentration can be a useful biomarker for the ADHD diagnosis, its severity, and comorbidity with overweight/obesity in these patients.
期刊介绍:
Archives of Medical Research serves as a platform for publishing original peer-reviewed medical research, aiming to bridge gaps created by medical specialization. The journal covers three main categories - biomedical, clinical, and epidemiological contributions, along with review articles and preliminary communications. With an international scope, it presents the study of diseases from diverse perspectives, offering the medical community original investigations ranging from molecular biology to clinical epidemiology in a single publication.